Karolina Vilval
General Counsel at SEDANA MEDICAL AB
Profile
Karolina Vilval currently works at Oncopeptides Incentive AB, as Director and Sedana Medical AB, as General Counsel from 2022.
Ms. Vilval also formerly worked at Gilead Sciences Sweden AB, as Associate Director-Legal, Biovitrum AB, as Head-Legal Affairs, Oncopeptides AB, as General Counsel from 2020 to 2022, and Swedish Orphan Biovitrum AB, as Head-Legal Affairs.
Ms. Vilval received her graduate degree from the University of Stockholm.
Karolina Vilval active positions
| Companies | Position | Start |
|---|---|---|
| SEDANA MEDICAL AB | General Counsel | 2022-07-31 |
| Oncopeptides Incentive AB | Director/Board Member | - |
Former positions of Karolina Vilval
| Companies | Position | End |
|---|---|---|
| ONCOPEPTIDES AB | General Counsel | 2022-07-31 |
| Gilead Sciences Sweden AB | General Counsel | - |
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | General Counsel | - |
Training of Karolina Vilval
| University of Stockholm | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| SEDANA MEDICAL AB | Health Technology |
| Private companies | 3 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Gilead Sciences Sweden AB | |
| Oncopeptides Incentive AB |
- Stock Market
- Insiders
- Karolina Vilval
